SCHEMBL1665170

SCHEMBL1665170

Cn1nccc1C(=O)Nc1ccc(Nc2ccc(Nc3ccc(N4CCC(O)CC4)cc3)cc2F)cc1

nearest known ligand 0.45

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 5/20 0.45
RAB9A P51151 5/20 0.45
CYP1A2 P05177 1/20 0.45
CYP2D6 P10635 1/20 0.45
CYP2C19 P33261 1/20 0.45
PKM P14618 1/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
PDE7A Q13946 3/20 0.41
HPGDS O60760 1/20 0.40
ALDH1A1 P00352 1/20 0.39
NAMPT P43490 1/20 0.39
MAPK10 P53779 1/20 0.39
DGAT1 O75907 3/20 0.39
GAA P10253 1/20 0.39
MAPT P10636 1/20 0.39
HTT P42858 1/20 0.38
MAPK8 P45983 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1664923 0.97 NPC1 (0.46) NPC1RAB9ACYP1A2CYP2D6CYP2C19
SCHEMBL6126242 0.96 NPC1 (0.45) NPC1RAB9ACYP1A2CYP2D6CYP2C19
SCHEMBL1664925 0.94 SLC2A1 (0.45) NPC1RAB9ACYP1A2CYP2D6CYP2C19
SCHEMBL1665171 0.94 SLC2A1 (0.45) NPC1RAB9ACYP1A2CYP2D6CYP2C19
SCHEMBL6126243 0.90 SLC2A1 (0.46) NPC1RAB9ACYP1A2CYP2D6CYP2C19
SCHEMBL1664481 0.87 SMN1; SMN2 (0.45) NPC1RAB9ACYP1A2CYP2D6CYP2C19
SCHEMBL1664625 0.86 RAB9A (0.48) NPC1RAB9ACYP1A2CYP2D6CYP2C19
SCHEMBL1664007 0.86 RAB9A (0.51) NPC1RAB9ACYP1A2CYP2D6CYP2C19
SCHEMBL1665043 0.85 NPC1 (0.42) NPC1RAB9ACYP1A2CYP2D6CYP2C19
SCHEMBL1663915 0.85 PDE7A (0.42) NPC1RAB9ASMN1; SMN2PDE7AHPGDS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2642994-A2 USE OF HEMATOPOIETIC GROWTH FACTOR MIMETICS Ligand Pharmaceuticals Incorporated (US) 2013-10-02 EP disclosed
EP-2488486-A1 HEMATOPOIETIC GROWTH FACTOR MIMETIC SMALL MOLECULE COMPOUNDS AND THEIR USES Ligand Pharmaceuticals Inc. (US) 2012-08-22 EP disclosed
WO-2012068406-A2 USE OF HEMATOPOIETIC GROWTH FACTOR MIMETICS LIGAND PHARMACEUTICALS INCORPORATED (US) 2012-05-24 WO disclosed
WO-2011046954-A1 HEMATOPOIETIC GROWTH FACTOR MIMETIC SMALL MOLECULE COMPOUNDS AND THEIR USES LIGAND PHARMACEUTICALS INC. (US) 2011-04-21 WO disclosed